News

Latest

Sep 18, 2020
The Centers for Disease Control and Prevention updated its testing guidance for SARS-CoV-2, the virus that causes COVID-19.
Sep 18, 2020 by Rick Pollack
The Centers for Medicare & Medicaid Services will withdraw its Medicaid fiscal accountability proposed rule from its regulatory agenda.
Sep 17, 2020
Government Accountability Office agents made 31 covert phone calls to selected sales representatives in five states between November 2019 and January 2020, posing as individuals needing to purchase health insurance to cover pre-existing conditions to see whether the representatives engaged in deceptive practices.
Sep 17, 2020
An estimated 29.6 million (9.2%) U.S. residents lacked health coverage when surveyed in 2019, up from 28.6 million (8.9%) in 2018, according to American Community Survey data reported by the Census Bureau.
Sep 17, 2020
The Centers for Disease Control and Prevention has released evidence-based recommendations to prevent and control Staphylococcus aureus in neonatal intensive care units, including strains resistant (MRSA) or sensitive (MSSA) to the antibiotic methicillin.
Sep 17, 2020
The Department of Health and Human Services declared a public health emergency and waived certain Medicare, Medicaid and Children’s Health Insurance Program requirements in Oregon due to wildfires.
Sep 17, 2020
Each year roughly 400 physicians die by suicide in the U.S. Hundreds more report harboring serious thoughts of suicide.
Sep 17, 2020
In a new AHA blog, Aaron Wesolowski, AHA’s vice president of policy research, analytics and strategy, sets the record straight about false narratives portraying hospitals and health systems as uniquely responsible for increased health care prices, and using these narratives in attempts to deny hospitals and health systems the financial relief they desperately need.
Sep 17, 2020
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently posted new and updated COVID-19 resources at its Technical Resources, Assistance Center, and Information Exchange.
Sep 17, 2020
The Food and Drug Administration approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and mechanically ventilated patients in an intensive-care setting and of non-intubated patients prior to and/or during surgical and other procedures.